AstraZeneca UK Limited

Horizon Place, 600 Capability Green, Luton, Bedfordshire, LU1 3LU
Telephone: +44 (0)1582 836 000
Fax: +44 (0)1582 838 000
Medical Information Direct Line: +44 (0)1582 836 836
Medical Information e-mail: medical.informationuk@astrazeneca.com
Customer Care direct line: +44 (0)1582 837 837
Medical Information Fax: +44 (0)1582 838 003

Patient Information Leaflet last updated on the eMC: 23/07/2010
PIL Accolate 20mg Film-coated Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 23/07/2010 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
Updated on 15/06/2010 and displayed until 23/07/2010
Reasons for adding or updating:
  • Change of trade or generic name
Updated on 25/06/2008 and displayed until 15/06/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change due to user-testing of patient information
Updated on 19/01/2005 and displayed until 25/06/2008
Reasons for adding or updating:
  • Change to instructions about overdose
  • Change to side-effects
Updated on 07/09/2004 and displayed until 19/01/2005
Reasons for adding or updating:
  • Change to date of revision
Updated on 17/03/2004 and displayed until 07/09/2004
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 26/09/2002 and displayed until 17/03/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 14/09/2000 and displayed until 26/09/2002
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   zafirlukast